跳至主要内容
临床试验/JPRN-jRCTs061180053
JPRN-jRCTs061180053已完成2 期

A clinical study evaluating the effectiveness of Lactobacillusvaginal suppositories in patients with recurrent urinary tract infection - A study evaluating the effectiveness of Lactobacillus vaginal suppositories in recurrent urinary tract infection

ISHII AYANO0 个研究点目标入组 28 人开始时间: 2019年3月14日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
28

研究概览

简要总结

Patients with recurrent cystitis were instructed to insert one vaginal suppository for 1 year. 21 completed the study. The mean patient age was 68.3. The number of recurrences of cystitis could be suppressed by 70% or more were 9 of the 21(43%) patients and 13 (62%) patients, during and after administration each other.The median number of recurrences of urinary tract infections was a significant reduction . In some cases, L. crispatus could be confirmed from the vagina. No adverse events were observed.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
Female

入选标准

  • 1) Acute simple cystitis
  • 2) Acute exacerbation of chronic complicated cystitis occurring in patients using clean intermittent catheterization
  • 3) Acute exacerbation of chronic complicated cystitis in neurogenic bladder and overactive bladder with residual urine volume of 50 mL or less
  • 4) Other acute exacerbations of chronic complicated cystitis occurred in mild basic disease of the urinary tract
  • The episode of urinary tract infection in need of intervention corresponding to any one of the above 1) to 4) has been found twice or more in the recent 1 year and the female patients of below 1) to 3)
  • 1) Patients who have already completed treatment with urinary tract infection antibiotics
  • 2) Patients over 20 years old
  • 3) Outpatient(Non-hospitalized patient)

排除标准

  • 1) Patients requiring urological treatment such as urolithiasis, hydronephrosis, urinary tract tumors
  • 2) Patient indwelling urethral catheter
  • 3) Patients with severe underlying disease and complications such as poorly controlled diabetes, collagen disease, leukemia, advanced cancer, congestive heart failure, severe liver or renal dysfunction
  • 4) Patients who had seen allergic hypersensitivity symptoms by ingestion of dairy products or lactobacillus products in the past
  • 5) Patients who have sex partner, whose partner have had allergic hypersensitivity symptoms by ingestion of dairy products or lactobacillus products in the past
  • 6) Patients who wish to have babies within one year and patients who are pregnant
  • 7) Patients who were judged inappropriate as subjects of this study by doctors

研究者

发起方
ISHII AYANO

相似试验